论文部分内容阅读
Aim: Observational studies show that regular use of aspirin after diagnosis was associated with longer survival among patients with mutated-PIK3CA colorectal cancer, but not among patients with PIK3CA wild-type cancer.ABT-737, a potent small-molecule inhibitor of antiapoptotic members of the Bcl-2 family,is a promising therapeutic agent for multiple malignancies.We examined the anti-cancer activity of 2 chemotherapeutic agents (aspirin and ABT-737) in several PIK3CA wild-type cancer cells.